Response to Maltoni, Puccetti, Poli, et al

Steffi Oesterreich^{1

2

3}, Adrian V Lee^{1

2

3}, Neil Carleton¹

Affiliations

¹ Women's Cancer Research Center, Magee-Women's Research Institute, University of Pittsburgh, PA, USA.
² Cancer Biology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.
³ Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Comment

Steffi Oesterreich et al. J Natl Cancer Inst. 2023.

. 2023 Apr 11;115(4):479-481.

doi: 10.1093/jnci/djad022.

Steffi Oesterreich^{1

2

3}, Adrian V Lee^{1

2

3}, Neil Carleton¹

¹ Women's Cancer Research Center, Magee-Women's Research Institute, University of Pittsburgh, PA, USA.
² Cancer Biology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.
³ Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to report.

Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer.
Maltoni R, Puccetti M, Poli F, Martinelli G, Bravaccini S. Maltoni R, et al. J Natl Cancer Inst. 2023 Apr 11;115(4):477-478. doi: 10.1093/jnci/djad021. J Natl Cancer Inst. 2023. PMID: 36762843 Free PMC article. No abstract available.

1. Maltoni R, Puccetti M, Poli F, Martinello G, Bravaccini S. Re: clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer. J Natl Cancer Inst. 2023;115(4):477-478. - PMC - PubMed
1. Weiser R, Polychronopoulou E, Hatch SS, et al. Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: a National Cancer Database analysis. Cancer. 2022;128(9):1738-1747. doi: 10.1002/cncr.34127. - DOI - PubMed
1. Abel MK, Shui AM, Melisko M, et al. The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study. NPJ Breast Cancer. 2021;7(1):156. doi: 10.1038/s41523-021-00366-x. - DOI - PMC - PubMed
1. Thomas M, Kelly ED, Abraham J, Kruse M.. Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease. Semin Oncol. 2019;46(2):121-132. doi: 10.1053/j.seminoncol.2019.03.002. - DOI - PubMed
1. Ciriello G, Gatza ML, Beck AH, et al. ; for the TCGA Research Network. Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 2015;163(2):506-519. doi: 10.1016/j.cell.2015.09.033. - DOI - PMC - PubMed